JBS
JBS
JBS N.V.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $126.27B ▲ | $10.08B ▲ | $2.27B ▼ | 1.8% ▼ | $2.25 ▲ | $8.59B ▼ |
| Q3-2025 | $120.55B ▲ | $9.35B ▼ | $3.1B ▲ | 2.57% ▲ | $0.52 ▼ | $11.47B ▲ |
| Q2-2025 | $118.97B ▲ | $9.78B ▼ | $3.04B ▲ | 2.55% ▼ | $1.37 ▲ | $7.78B ▼ |
| Q1-2025 | $114.13B ▼ | $10.18B ▼ | $2.92B ▲ | 2.56% ▲ | $1.32 ▲ | $9.61B ▲ |
| Q4-2024 | $116.7B | $11.75B | $2.41B | 2.07% | $1.09 | $9.37B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $25.98B ▲ | $248.34B ▲ | $195.97B ▲ | $47.87B ▲ |
| Q3-2025 | $3.56B ▼ | $44.19B ▼ | $34.68B ▼ | $8.72B ▼ |
| Q2-2025 | $13.67B ▼ | $228.12B ▼ | $177.73B ▼ | $45.88B ▲ |
| Q1-2025 | $27.71B ▼ | $239.48B ▼ | $192.07B ▼ | $43.31B ▼ |
| Q4-2024 | $34.76B | $251.94B | $201.57B | $44.78B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $2.27B ▲ | $10.66B ▲ | $-4.76B ▼ | $-307.92M ▼ | $5.64B ▲ | $6B ▲ |
| Q3-2025 | $587.23M ▼ | $1.06B ▼ | $-584.13M ▲ | $680.6M ▲ | $1.05B ▲ | $542.79M ▲ |
| Q2-2025 | $3.04B ▲ | $2.94B ▲ | $-3.48B ▼ | $-13.03B ▼ | $-14.04B ▼ | $389.59M ▲ |
| Q1-2025 | $2.92B ▲ | $-3.24B ▼ | $-1.42B ▲ | $-204.28M ▲ | $-7.05B ▼ | $-4.79B ▼ |
| Q4-2024 | $2.41B | $9B | $-2.88B | $-2.58B | $3.29B | $5.9B |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at JBS N.V.'s financial evolution and strategic trajectory over the past five years.
JBS combines a massive global revenue base, solid operating profitability, and strong cash generation with a wide geographic and product footprint. Its scale, vertical integration, and established brands provide meaningful competitive advantages. The asset base is substantial, liquidity is generally supportive, and the company continues to invest heavily in its operations and in new technologies, including alternative proteins and advanced processing. Together, these factors underpin its position as a key player in global food supply.
The most notable risks are high leverage, thin net margins, and exposure to volatile and highly scrutinized meat markets. Elevated debt and interest costs limit financial flexibility and magnify the impact of downturns or shocks. The business also faces ongoing ESG, regulatory, and reputational challenges tied to environmental impact, animal welfare, and labor practices. In addition, long-term shifts toward plant-based or lower-meat diets, intensified competition, and execution risks in new technologies like cultivated meat could all weigh on future performance.
Based on the available information, JBS looks like a mature, stable operator with robust operational cash flows and a clear strategy to modernize and diversify its protein offerings. The outlook appears balanced: its scale, investment in efficiency, and moves into higher-value and alternative products support resilience, while leverage, sector volatility, and ESG pressures remain important headwinds. Future performance will likely hinge on disciplined debt management, sustained operational excellence, and the company’s ability to turn its innovation agenda—especially in value-added and new proteins—into durable, profitable growth.
About JBS N.V.
https://www.jbs.com.brJBS N.V., together with its subsidiaries, operates as a protein and food company worldwide. The company offers beef, pork, chicken, poultry, fish, and lamb products; cooked frozen meat; plant based products; and other food products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $126.27B ▲ | $10.08B ▲ | $2.27B ▼ | 1.8% ▼ | $2.25 ▲ | $8.59B ▼ |
| Q3-2025 | $120.55B ▲ | $9.35B ▼ | $3.1B ▲ | 2.57% ▲ | $0.52 ▼ | $11.47B ▲ |
| Q2-2025 | $118.97B ▲ | $9.78B ▼ | $3.04B ▲ | 2.55% ▼ | $1.37 ▲ | $7.78B ▼ |
| Q1-2025 | $114.13B ▼ | $10.18B ▼ | $2.92B ▲ | 2.56% ▲ | $1.32 ▲ | $9.61B ▲ |
| Q4-2024 | $116.7B | $11.75B | $2.41B | 2.07% | $1.09 | $9.37B |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $25.98B ▲ | $248.34B ▲ | $195.97B ▲ | $47.87B ▲ |
| Q3-2025 | $3.56B ▼ | $44.19B ▼ | $34.68B ▼ | $8.72B ▼ |
| Q2-2025 | $13.67B ▼ | $228.12B ▼ | $177.73B ▼ | $45.88B ▲ |
| Q1-2025 | $27.71B ▼ | $239.48B ▼ | $192.07B ▼ | $43.31B ▼ |
| Q4-2024 | $34.76B | $251.94B | $201.57B | $44.78B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $2.27B ▲ | $10.66B ▲ | $-4.76B ▼ | $-307.92M ▼ | $5.64B ▲ | $6B ▲ |
| Q3-2025 | $587.23M ▼ | $1.06B ▼ | $-584.13M ▲ | $680.6M ▲ | $1.05B ▲ | $542.79M ▲ |
| Q2-2025 | $3.04B ▲ | $2.94B ▲ | $-3.48B ▼ | $-13.03B ▼ | $-14.04B ▼ | $389.59M ▲ |
| Q1-2025 | $2.92B ▲ | $-3.24B ▼ | $-1.42B ▲ | $-204.28M ▲ | $-7.05B ▼ | $-4.79B ▼ |
| Q4-2024 | $2.41B | $9B | $-2.88B | $-2.58B | $3.29B | $5.9B |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at JBS N.V.'s financial evolution and strategic trajectory over the past five years.
JBS combines a massive global revenue base, solid operating profitability, and strong cash generation with a wide geographic and product footprint. Its scale, vertical integration, and established brands provide meaningful competitive advantages. The asset base is substantial, liquidity is generally supportive, and the company continues to invest heavily in its operations and in new technologies, including alternative proteins and advanced processing. Together, these factors underpin its position as a key player in global food supply.
The most notable risks are high leverage, thin net margins, and exposure to volatile and highly scrutinized meat markets. Elevated debt and interest costs limit financial flexibility and magnify the impact of downturns or shocks. The business also faces ongoing ESG, regulatory, and reputational challenges tied to environmental impact, animal welfare, and labor practices. In addition, long-term shifts toward plant-based or lower-meat diets, intensified competition, and execution risks in new technologies like cultivated meat could all weigh on future performance.
Based on the available information, JBS looks like a mature, stable operator with robust operational cash flows and a clear strategy to modernize and diversify its protein offerings. The outlook appears balanced: its scale, investment in efficiency, and moves into higher-value and alternative products support resilience, while leverage, sector volatility, and ESG pressures remain important headwinds. Future performance will likely hinge on disciplined debt management, sustained operational excellence, and the company’s ability to turn its innovation agenda—especially in value-added and new proteins—into durable, profitable growth.

CEO
Gilberto Tomazoni
Compensation Summary
(Year )
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 96
Ratings Snapshot
Rating : A
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
BLACKROCK, INC.
Shares:25.54M
Value:$450.82M
DAVIS SELECTED ADVISERS
Shares:11.85M
Value:$209.24M
D. E. SHAW & CO., INC.
Shares:9.73M
Value:$171.69M
Summary
Showing Top 3 of 270

